tirzepatide and crohn's COMMIT-CD: A Phase 3b trial evaluating the efficacy & safety of concomitant use of a dual GLP-1/GIP receptor agonist & IL-23p19 antagonist in adult participants with moderately to severely active disease Ozempic and Crohn's Disease: Could

While cumulative evidence has demonstrated that mitochondrial metabolism reprogramming plays crucial roles in the promotion of cancer progression, the molecular mechanisms underlying the alterations of mitochondrial metabolism in cancer cells remain incompletely understood

Oral Semaglutide Drops Information for Patients: Gradual Dose Increases: Starting with a smaller dose and gradually increasing is commonly recommended to reduce side effects like nausea

In case of difficulty swallowing or a mass in the thyroid, consult your doctor, as semaglutide is contraindicated in patients with thyroid tumors or those with personal or family history of thyroid cancer

Understanding the full side effect profile helps you know what is expected versus what requires medical attention